2021 Summit Speakers

2022 Summit Speakers

2023 Summit Speakers

John Driscoll

EVP & President U.S. Healthcare, Walgreens Boots Alliance

John Driscoll, Executive Vice President and President, U.S. Healthcare, brings more than 25 years of health care experience to Walgreens Boots Alliance, Inc. Driscoll oversees U.S. Healthcare for WBA with responsibility for Walgreens healthcare assets including VillageMD, Shields Health Solutions and Carecentrix, Walgreens acquisitions team, PBM contracting as well as Walgreens organic health care initiatives across the enterprise.
Driscoll joined WBA in October 2022, when WBA acquired ownership of CareCentrix, where he served as Chief Executive Officer since 2013. CareCentrix is now an integral part of WBA’s U.S. Healthcare segment and the only independent, home-centered platform that coordinates care to the home for health plans, patients and providers.
Prior to CareCentrix, Driscoll served as President at Castlight, a healthcare technology company. Previously, he served as Group President for new markets at Medco, where he led all acquisitions and investments, retail contracting and developed the first ‘five star’ Medicare part D plan. He also founded and chaired the Surescripts ePrescribing Network, building the first cross-industry technology collaborative with competing Retail, PBM, and Health Plans cooperating to enable e-prescribing nationally.
Earlier in his career, Driscoll was a member of the executive team at Oxford Health Plans, serving as Corporate Vice President for government programs. In addition, he was selected by the White House for its Entrepreneurs in Residence program in 2011 to advise the Food and Drug Administration on new paths for innovation.

He has a B.A. and M.B.A. from Harvard University and holds an MPhil from Cambridge University in England. Driscoll served as a Captain in the U.S. Army Reserve. He chairs the Waystar Corporation as well as serves on the boards of directors of the Alliance for Hunger, Business Executives for National Security and Johns Hopkins Medicine.